Kaya Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Kaya Ltd is ₹ 280.6 as of 23 Oct 15:30 . The P/E Ratio of Kaya Ltd changed from 3.7 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Kaya Ltd changed from ₹ 387.09 crore on March 2021 to ₹ 361.84 crore on March 2026 . This represents a CAGR of -1.12% over 6 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Kaya Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 61.54 crore. This represent the decline of -100% The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The ebitda of Kaya Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -6.94 crore. This represent the decline of -100% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The net profit of Kaya Ltd changed from ₹ 102.7 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Kaya Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Kaya Ltd

Kaya Limited was formerly incorporated as Kaya Skin Care Limited on March 27, 2003.
The Company name was changed from Kaya Skin Care Limited to Kaya Limited in March, 2012.
The Company, headquartered in Mumbai, carries on Skin Care Business in India and through its subsidiary in Middle East region.
Up to March 31, 2013, the Kaya Business was conducted as subsidiaries of Marico Limited.
Following the demerger, of Kaya business from Marico Limited in September, 2013 the Kaya Business has been conducted by the Company and its subsidiaries. Kaya has pioneered into aesthetic dermatology in India and the Middle East.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Kaya Ltd and null

Which company has a larger market capitalization, Kaya Ltd or Molbio Diagnostics Ltd?

Market cap of Kaya Ltd is 426 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Kaya Ltd and Molbio Diagnostics Ltd?

The stock performance of Kaya Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kaya Ltd and Molbio Diagnostics Ltd?

As of October 26, 2026, the Kaya Ltd stock price is INR ₹280.6. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Kaya Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Kaya Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.